首页 > 最新文献

INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE最新文献

英文 中文
Comparison of QTc interval changes in drug-resistant tuberculosis patients on delamanid-containing regimens versus shorter treatment regimens. 比较耐药结核病患者接受含地拉马尼治疗方案与短程治疗方案的 QTc 间期变化。
IF 1.7 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/JRS-230024
H Y Jefman Efendi Marzuki, Nafrialdi Nafrialdi, Neni Sawitri, Yani Jane Sugiri, I Gusti Agung Ayu Putu Sri Darmayani, Purwantyastuti Ascobat

Background: Delamanid (DLM) is a relatively new drug for drug-resistant tuberculosis (DR-TB) that has been used in Indonesia since 2019 despite its limited safety data. DLM is known to inhibit hERG potassium channel with the potential to cause QT prolongation which eventually leads to Torsades de pointes (TdP).

Objective: This study aims to analyse the changes of QTc interval in DR-TB patients on DLM regimen compared to shorter treatment regimens (STR).

Methods: A retrospective cohort was implemented on secondary data obtained from two participating hospitals. The QTc interval and the changes in QTc interval from baseline (ΔQTc) were assessed every 4 weeks for 24 weeks.

Results: The maximum increased of QTc interval and ΔQTc interval were smaller in the DLM group with mean difference of 18,6 (95%CI 0.3 to 37.5) and 31.6 milliseconds (95%CI 14.1 to 49.1) respectively. The proportion of QTc interval prolongation in DLM group were smaller than STR group (RR=0.62; 95%CI 0.42 to 0.93).

Conclusion: This study has shown that DLM regimens are less likely to increase QTc interval compared to STR. However, close monitoring of the risk of QT interval prolongation needs to be carried out upon the use of QT interval prolonging antituberculoid drugs.

背景:地拉那米(DLM)是一种治疗耐药性结核病(DR-TB)的相对较新的药物,尽管其安全性数据有限,但自2019年以来一直在印度尼西亚使用。众所周知,DLM可抑制hERG钾通道,可能导致QT延长,最终导致Torsades de pointes(TdP):本研究旨在分析与短期治疗方案(STR)相比,使用 DLM 方案的 DR-TB 患者 QTc 间期的变化:方法:根据从两家参与研究的医院获得的二手数据进行回顾性队列研究。方法:根据从两家参与医院获得的二级数据进行回顾性队列,在 24 周内每 4 周评估一次 QTc 间期和 QTc 间期与基线相比的变化(ΔQTc):结果:DLM 组 QTc 间期和 ΔQTc 间期的最大增幅较小,平均差异分别为 18.6 毫秒(95%CI 0.3 至 37.5)和 31.6 毫秒(95%CI 14.1 至 49.1)。DLM组QTc间期延长的比例小于STR组(RR=0.62;95%CI 0.42至0.93):本研究表明,与 STR 相比,DLM 方案增加 QTc 间期的可能性较小。结论:本研究表明,与 STR 相比,DLM 方案不易导致 QTc 间期延长,但在使用 QT 间期延长的抗结核药物时,需要密切监测 QT 间期延长的风险。
{"title":"Comparison of QTc interval changes in drug-resistant tuberculosis patients on delamanid-containing regimens versus shorter treatment regimens.","authors":"H Y Jefman Efendi Marzuki, Nafrialdi Nafrialdi, Neni Sawitri, Yani Jane Sugiri, I Gusti Agung Ayu Putu Sri Darmayani, Purwantyastuti Ascobat","doi":"10.3233/JRS-230024","DOIUrl":"10.3233/JRS-230024","url":null,"abstract":"<p><strong>Background: </strong>Delamanid (DLM) is a relatively new drug for drug-resistant tuberculosis (DR-TB) that has been used in Indonesia since 2019 despite its limited safety data. DLM is known to inhibit hERG potassium channel with the potential to cause QT prolongation which eventually leads to Torsades de pointes (TdP).</p><p><strong>Objective: </strong>This study aims to analyse the changes of QTc interval in DR-TB patients on DLM regimen compared to shorter treatment regimens (STR).</p><p><strong>Methods: </strong>A retrospective cohort was implemented on secondary data obtained from two participating hospitals. The QTc interval and the changes in QTc interval from baseline (ΔQTc) were assessed every 4 weeks for 24 weeks.</p><p><strong>Results: </strong>The maximum increased of QTc interval and ΔQTc interval were smaller in the DLM group with mean difference of 18,6 (95%CI 0.3 to 37.5) and 31.6 milliseconds (95%CI 14.1 to 49.1) respectively. The proportion of QTc interval prolongation in DLM group were smaller than STR group (RR=0.62; 95%CI 0.42 to 0.93).</p><p><strong>Conclusion: </strong>This study has shown that DLM regimens are less likely to increase QTc interval compared to STR. However, close monitoring of the risk of QT interval prolongation needs to be carried out upon the use of QT interval prolonging antituberculoid drugs.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interprofessional collaboration mediates the relationship between perceived organizational learning and safety climate in hospitals: A cross-sectional study. 专业间合作对医院组织学习感知与安全氛围之间关系的中介作用:一项横断面研究。
IF 0.9 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-01-01 DOI: 10.3233/JRS-230026
Keiko Ishii, Katsumi Fujitani, Hironobu Matsushita

Background: Organizational learning (OL) and interprofessional collaboration (IPC) are said to enhance medical safety in hospitals, but the relationship between these variables has not been quantitatively tested.

Objective: This study examines the mediating effects of IPC on the relationship between OL and safety climate (improvement, compliance, and patient/family involvement).

Methods: An anonymous self-reporting questionnaire was administered to 1,495 healthcare workers from November 2021 to January 2022. The questions regarded the hospital's safety climate, OL, and IPC. A mediation analysis using structural equation modeling was conducted to examine the mediating role of IPC on the relationship between OL and the three safety climates. The indirect effect was estimated using 2,000 bootstrap samples.

Results: Responses from 643 healthcare workers were analyzed. The direct effects of OL were 𝛽 = .74, 75 (p < .001) on improvement and involvement and 𝛽 = 0.1 (p > .05) on compliance. The indirect effects of IPC on improvement and involvement were 𝛽 = .14 (95%CI: .00 ∼ .06) and 𝛽 = .37 (95%CI: .04 ∼ .09), respectively.

Conclusion: This study determined the mechanisms that enhance a hospital's safety climate, demonstrating that IPC mediates the relationship between OL and improvement and patient/family involvement. However, OL and IPC are not related to compliance.

背景:据说组织学习(OL)和跨专业协作(IPC)可以提高医院的医疗安全,但这些变量之间的关系尚未得到定量测试:本研究探讨了 IPC 对 OL 与安全氛围(改善、依从性和患者/家属参与)之间关系的中介效应:方法:2021 年 11 月至 2022 年 1 月期间,对 1495 名医护人员进行了匿名自我报告问卷调查。问题涉及医院的安全氛围、OL 和 IPC。通过结构方程模型进行中介分析,研究 IPC 对 OL 与三种安全氛围之间关系的中介作用。使用 2,000 个自举样本对间接效应进行了估计:结果:分析了 643 名医护人员的回答。OL 对依从性的直接影响为 ¼ = .74, 75 (p .05)。IPC对改善和参与的间接影响分别为:.14(95%CI:.00 ∼ .06)和.37(95%CI:.04 ∼ .09):本研究确定了提升医院安全氛围的机制,表明 IPC 在 OL 与改进和患者/家属参与之间起到了中介作用。然而,OL 和 IPC 与依从性无关。
{"title":"Interprofessional collaboration mediates the relationship between perceived organizational learning and safety climate in hospitals: A cross-sectional study.","authors":"Keiko Ishii, Katsumi Fujitani, Hironobu Matsushita","doi":"10.3233/JRS-230026","DOIUrl":"10.3233/JRS-230026","url":null,"abstract":"<p><strong>Background: </strong>Organizational learning (OL) and interprofessional collaboration (IPC) are said to enhance medical safety in hospitals, but the relationship between these variables has not been quantitatively tested.</p><p><strong>Objective: </strong>This study examines the mediating effects of IPC on the relationship between OL and safety climate (improvement, compliance, and patient/family involvement).</p><p><strong>Methods: </strong>An anonymous self-reporting questionnaire was administered to 1,495 healthcare workers from November 2021 to January 2022. The questions regarded the hospital's safety climate, OL, and IPC. A mediation analysis using structural equation modeling was conducted to examine the mediating role of IPC on the relationship between OL and the three safety climates. The indirect effect was estimated using 2,000 bootstrap samples.</p><p><strong>Results: </strong>Responses from 643 healthcare workers were analyzed. The direct effects of OL were 𝛽 = .74, 75 (p < .001) on improvement and involvement and 𝛽 = 0.1 (p > .05) on compliance. The indirect effects of IPC on improvement and involvement were 𝛽 = .14 (95%CI: .00 ∼ .06) and 𝛽 = .37 (95%CI: .04 ∼ .09), respectively.</p><p><strong>Conclusion: </strong>This study determined the mechanisms that enhance a hospital's safety climate, demonstrating that IPC mediates the relationship between OL and improvement and patient/family involvement. However, OL and IPC are not related to compliance.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of risk management status in selected departments of educational hospitals of Hamadan University of Medical Sciences. 哈马丹医科大学教育医院部分科室风险管理状况评估。
IF 1.7 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/JRS-220066
Ali Mohammadpour, Hamid Bouraghi, Taleb Khodaveisi, Behzad Imani, Karim Ghazikhanlousani, Rasool Azmoonfar, Hossein Khosravi, Hassan Rafieemehr

Background: Healthcare organizations are among high-risk organizations due to the nature of their work as well as structural, physical and technological complexities. Accordingly, it is important to use risk management and control programs in all departments of these organizations.

Objective: The present study was conducted for the first time to evaluate the risk management status of the operating room and laboratory departments of Hamadan hospitals in 2022.

Methods: In this descriptive-observational cross-sectional study, laboratory and operating room departments were selected as the research environment. To conduct this research, a valid and reliable questionnaire was used to collect data, and the data were analyzed using SPSS 22 statistical software.

Results: The findings of the present study showed that the overall mean score of risk management status for the laboratory and operating room departments was 2.66 ± 0.15 and 2.89 ± 0.13, respectively. Furthermore, there was no statistically significant difference in the mean scores of the research components based on work experience, education level, and gender.

Conclusion: It is suggested that the laboratory and operating room departments should focus more on adopting policies and solutions to improve the position of risk management, training and budget allocation for risk management.

背景:由于工作性质以及结构、物理和技术的复杂性,医疗机构属于高风险机构。因此,在这些机构的所有部门使用风险管理和控制程序非常重要:本研究首次对 2022 年哈马丹医院手术室和实验室部门的风险管理状况进行了评估:在这项描述性观察横断面研究中,选择实验室和手术室部门作为研究环境。为了开展这项研究,我们使用了有效可靠的问卷来收集数据,并使用 SPSS 22 统计软件对数据进行了分析:本研究结果显示,实验室和手术室的风险管理状况总平均得分分别为(2.66±0.15)分和(2.89±0.13)分。此外,根据工作经验、教育水平和性别的不同,研究内容的平均得分也没有明显的统计学差异:建议实验室和手术室部门应更加注重采取政策和解决方案,以改善风险管理的地位、培训和风险管理的预算分配。
{"title":"Evaluation of risk management status in selected departments of educational hospitals of Hamadan University of Medical Sciences.","authors":"Ali Mohammadpour, Hamid Bouraghi, Taleb Khodaveisi, Behzad Imani, Karim Ghazikhanlousani, Rasool Azmoonfar, Hossein Khosravi, Hassan Rafieemehr","doi":"10.3233/JRS-220066","DOIUrl":"10.3233/JRS-220066","url":null,"abstract":"<p><strong>Background: </strong>Healthcare organizations are among high-risk organizations due to the nature of their work as well as structural, physical and technological complexities. Accordingly, it is important to use risk management and control programs in all departments of these organizations.</p><p><strong>Objective: </strong>The present study was conducted for the first time to evaluate the risk management status of the operating room and laboratory departments of Hamadan hospitals in 2022.</p><p><strong>Methods: </strong>In this descriptive-observational cross-sectional study, laboratory and operating room departments were selected as the research environment. To conduct this research, a valid and reliable questionnaire was used to collect data, and the data were analyzed using SPSS 22 statistical software.</p><p><strong>Results: </strong>The findings of the present study showed that the overall mean score of risk management status for the laboratory and operating room departments was 2.66 ± 0.15 and 2.89 ± 0.13, respectively. Furthermore, there was no statistically significant difference in the mean scores of the research components based on work experience, education level, and gender.</p><p><strong>Conclusion: </strong>It is suggested that the laboratory and operating room departments should focus more on adopting policies and solutions to improve the position of risk management, training and budget allocation for risk management.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10157479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategy development to increase consumer intention of purchasing prescription drugs through e-pharmacy in Indonesia. 印度尼西亚通过电子药房提高消费者购买处方药意向的战略制定。
IF 1.7 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/JRS-220067
Bungaran Panggabean, Budi Suharjo, Ujang Sumarwan, Lilik Noor Yuliati

Background: The global COVID-19 pandemic has forced people to obtain health products and services from home. Similar to other e-commerce, medicines are bought online and delivered using a courier service.

Objective: By being fully concerned to patient safety, this study aims to determine development strategies to increase intention in purchasing prescription drugs through e-pharmacy.

Methods: Two stages of measurement are employed in this study, namely confirmatory factor analyis using PLS-SEM and pairwise comparison using AHP method. To discover consumer perception in using e-pharmacy, the basic model of Theory of Planned Behavior (TPB) is employed with several extensions.

Results: The results of PLS-SEM express that Trust has a major role as an intervening variable to enhance the indirect effect of Subjective Norms and Perceived Values on Purchase Intention. In general, PLS-SEM structural model is declared "fit" (GFI = 0.93 ≥ 0.90; RMSEA = 0.045 ≤ 0.08; SRMR = 0.033 ≤ 0.05). Measurement model test proves that all selected indicators are valid to represent their related constructs (Loading Factor ≥ 0.50), and all selected constructs are reliable to build the whole path model (CR ≥ 0.7; AVE ≥ 05). Meanwhile, the results of AHP indicate that strengthening government policies and regulations is prioritized to increase consumer intention of purchasing prescription drugs through e-pharmacy, followed by protection of user confidential data in the second place. Those two eigenvectors are 0.236 and 0.185 respectively.

Conclusion: Future research is suggested to add perceived risk as latent variable in the study of consumer behavior for any high-risk products.

背景:全球 COVID-19 大流行迫使人们从家中获取健康产品和服务。与其他电子商务类似,药品也是在网上购买,并通过快递服务送达:本研究旨在充分关注患者安全,确定发展战略,以提高通过电子药房购买处方药的意向:本研究采用了两个阶段的测量方法,即使用 PLS-SEM 进行确证因子分析和使用 AHP 方法进行配对比较。为了发现消费者在使用电子药店时的感知,本研究采用了计划行为理论(TPB)的基本模型,并对其进行了若干扩展:结果:PLS-SEM 的结果表明,信任作为一个干预变量,在增强主观规范和感知价值对购买意向的间接影响方面发挥了重要作用。总体而言,PLS-SEM 结构模型被宣布为 "拟合"(GFI = 0.93 ≥ 0.90;RMSEA = 0.045 ≤ 0.08;SRMR = 0.033 ≤ 0.05)。测量模型检验证明,所选指标均能有效地代表其相关构念(载荷因子≥0.50),所选构念均能可靠地构建整个路径模型(CR≥0.7;AVE≥05)。同时,AHP 的结果表明,加强政府政策法规建设是提高消费者通过电子药店购买处方药意向的优先考虑因素,其次是保护用户机密数据。这两个特征向量分别为 0.236 和 0.185:建议今后的研究在研究消费者对任何高风险产品的行为时,增加感知风险作为潜在变量。
{"title":"Strategy development to increase consumer intention of purchasing prescription drugs through e-pharmacy in Indonesia.","authors":"Bungaran Panggabean, Budi Suharjo, Ujang Sumarwan, Lilik Noor Yuliati","doi":"10.3233/JRS-220067","DOIUrl":"10.3233/JRS-220067","url":null,"abstract":"<p><strong>Background: </strong>The global COVID-19 pandemic has forced people to obtain health products and services from home. Similar to other e-commerce, medicines are bought online and delivered using a courier service.</p><p><strong>Objective: </strong>By being fully concerned to patient safety, this study aims to determine development strategies to increase intention in purchasing prescription drugs through e-pharmacy.</p><p><strong>Methods: </strong>Two stages of measurement are employed in this study, namely confirmatory factor analyis using PLS-SEM and pairwise comparison using AHP method. To discover consumer perception in using e-pharmacy, the basic model of Theory of Planned Behavior (TPB) is employed with several extensions.</p><p><strong>Results: </strong>The results of PLS-SEM express that Trust has a major role as an intervening variable to enhance the indirect effect of Subjective Norms and Perceived Values on Purchase Intention. In general, PLS-SEM structural model is declared \"fit\" (GFI = 0.93 ≥ 0.90; RMSEA = 0.045 ≤ 0.08; SRMR = 0.033 ≤ 0.05). Measurement model test proves that all selected indicators are valid to represent their related constructs (Loading Factor ≥ 0.50), and all selected constructs are reliable to build the whole path model (CR ≥ 0.7; AVE ≥ 05). Meanwhile, the results of AHP indicate that strengthening government policies and regulations is prioritized to increase consumer intention of purchasing prescription drugs through e-pharmacy, followed by protection of user confidential data in the second place. Those two eigenvectors are 0.236 and 0.185 respectively.</p><p><strong>Conclusion: </strong>Future research is suggested to add perceived risk as latent variable in the study of consumer behavior for any high-risk products.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139742289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications. 轮状病毒疫苗安全性的自控风险间隔研究:研究结果和影响。
IF 0.9 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-01-01 DOI: 10.3233/JRS-230049
Jacob Puliyel, Brian S Hooker

Background: The self-controlled case series (SCCS) is often used to monitor vaccine safety. The evaluation of intussusception after the rotavirus vaccine is complicated because the baseline rate varies with age. Time-varying baseline risk adjustments with data from unexposed cohorts are utilised. Self-controlled risk interval (SCRI), with a shorter observation period, can also mitigate the problem by studying a control period close to the risk period.

Objective: An Indian rotavirus vaccine has previously been studied using SCCS. The risk of intussusception in the high-risk windows (21 days after vaccination) was comparable to the background risk. The aim was to re-analyse data of an existing SCCS study using alternate statistical methods to examine vaccine safety.

Methods: We examined the mean age of intussusception in the vaccinated and the unvaccinated. We performed an SCRI analysis of the surveillance data from the SCCS study, limiting the observation period to 180 days. We analysed the time-to-intussusception from the last vaccination. Finally, we performed an SCCS analysis, excluding unvaccinated cases from the analysis.

Results: We found that the mean age of intussusception was significantly lower in the vaccinated (205 days) compared to the unvaccinated (223 days) (p-value 0.0026). The Incident Risk Ratio (IRR) on SCRI analysis was 1.62 (95% CI 1.07-2.44). There were significantly more intussusceptions in the first 30 days after vaccination compared to the next 30-day window. (92 vs 63 p-value = 0.009). We found that excluding unvaccinated infants from the SCCS analysis demonstrated significantly increased risk for the risk period 1-21 days after the 3rd dose (IRR 2.47, 95% CI 1.70-3.59). The risks of intussusception were missed in traditional SCCS analysis using unvaccinated infants as controls.

Conclusion: Traditional risk adjustments using data from unexposed cohorts in SCCS may not be appropriate for investigating the risk of intussusception where vaccination lowers the mean age of intussusception.

背景:自控病例系列(SCCS)通常用于监测疫苗的安全性。轮状病毒疫苗接种后肠梗阻的评估比较复杂,因为基线发病率随年龄而变化。利用未暴露人群的数据对时变基线风险进行调整。观察期较短的自控风险间隔期(SCRI)也可以通过研究接近风险期的对照期来缓解这一问题:目的:此前曾使用 SCCS 对印度轮状病毒疫苗进行过研究。高风险窗口期(接种疫苗后 21 天)发生肠套叠的风险与背景风险相当。我们的目的是使用其他统计方法重新分析现有 SCCS 研究的数据,以检查疫苗的安全性:我们研究了接种疫苗和未接种疫苗儿童肠套叠的平均发病年龄。我们对 SCCS 研究的监测数据进行了 SCRI 分析,将观察期限制为 180 天。我们分析了从最后一次接种疫苗到发生肠套叠的时间。最后,我们进行了 SCCS 分析,将未接种疫苗的病例排除在分析之外:结果:我们发现,接种疫苗者的肠套叠平均发生年龄(205 天)明显低于未接种者(223 天)(P 值为 0.0026)。根据 SCRI 分析得出的发病风险比为 1.62(95% CI 1.07-2.44)。接种后前 30 天内发生的肠套叠明显多于后 30 天。(92 vs 63 p-值 = 0.009)。我们发现,从 SCCS 分析中排除未接种疫苗的婴儿后,第 3 次接种后 1-21 天的风险期的风险明显增加(IRR 2.47,95% CI 1.70-3.59)。以未接种疫苗的婴儿为对照组进行的传统 SCCS 分析漏掉了肠套叠的风险:结论:在接种疫苗会降低肠套叠发生的平均年龄的情况下,使用 SCCS 中未暴露队列的数据进行传统的风险调整可能不适合调查肠套叠的风险。
{"title":"Self-controlled risk interval study of rotavirus vaccine safety: Findings and implications.","authors":"Jacob Puliyel, Brian S Hooker","doi":"10.3233/JRS-230049","DOIUrl":"10.3233/JRS-230049","url":null,"abstract":"<p><strong>Background: </strong>The self-controlled case series (SCCS) is often used to monitor vaccine safety. The evaluation of intussusception after the rotavirus vaccine is complicated because the baseline rate varies with age. Time-varying baseline risk adjustments with data from unexposed cohorts are utilised. Self-controlled risk interval (SCRI), with a shorter observation period, can also mitigate the problem by studying a control period close to the risk period.</p><p><strong>Objective: </strong>An Indian rotavirus vaccine has previously been studied using SCCS. The risk of intussusception in the high-risk windows (21 days after vaccination) was comparable to the background risk. The aim was to re-analyse data of an existing SCCS study using alternate statistical methods to examine vaccine safety.</p><p><strong>Methods: </strong>We examined the mean age of intussusception in the vaccinated and the unvaccinated. We performed an SCRI analysis of the surveillance data from the SCCS study, limiting the observation period to 180 days. We analysed the time-to-intussusception from the last vaccination. Finally, we performed an SCCS analysis, excluding unvaccinated cases from the analysis.</p><p><strong>Results: </strong>We found that the mean age of intussusception was significantly lower in the vaccinated (205 days) compared to the unvaccinated (223 days) (p-value 0.0026). The Incident Risk Ratio (IRR) on SCRI analysis was 1.62 (95% CI 1.07-2.44). There were significantly more intussusceptions in the first 30 days after vaccination compared to the next 30-day window. (92 vs 63 p-value = 0.009). We found that excluding unvaccinated infants from the SCCS analysis demonstrated significantly increased risk for the risk period 1-21 days after the 3rd dose (IRR 2.47, 95% CI 1.70-3.59). The risks of intussusception were missed in traditional SCCS analysis using unvaccinated infants as controls.</p><p><strong>Conclusion: </strong>Traditional risk adjustments using data from unexposed cohorts in SCCS may not be appropriate for investigating the risk of intussusception where vaccination lowers the mean age of intussusception.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141321790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A collaborative approach to develop indicators for quality of care for ST segment Elevation Myocardial Infarction in networks without coronary intervention: A position paper. 在无冠状动脉介入治疗的网络中制定ST段抬高心肌梗死护理质量指标的合作方法:立场文件。
IF 1.7 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/JRS-220057
Miguel Alejandro Rodríguez-Ramos, Maikel Santos-Medina, Alfredo Dueñas-Herrera, Juan Adolfo Prohías Martínez, Eduardo Rivas-Estany

Background: Data about performance measures (PM) in patients with ST segment Elevation Myocardial Infarction (STEMI) in low- and middle-income countries is really scarce. One of the reasons is the lack of appropriate measures for these scenarios where coronary intervention is not the standard treatment.

Objective: This study aimed to develop a set of PM and quality markers for patients with STEMI in these countries.

Methods: Two investigators systematically reviewed existing guidelines and scientific literature to identify potential PM by referring to documents searched through PubMed from 2010 through 2019, using terms "Myocardial Infarction", "STEMI", "quality indicator", and "performance measure". A modified Delphi technique, involving multidisciplinary panel interview, was used. A 15-member multidisciplinary expert panel individually rated each potential indicator on a scale of 1 (lowest) to 5 (highest) during three rounds. All indicators that received a median score ≥4.5, in final round without significant disagreement were included as PM.

Results: Through the consensus-building process, 84 potential indicators were found, of which 10 were proposed as performance measures and 2 as quality metrics, as follows: Pre-Hospital Electrocardiogram; Patients with reperfusion therapy; Pre-hospital Reperfusion; Ischemic time less than 120 minutes; System delay time less than 90 minutes; In-hospital Mortality; Complete in-hospital Treatment; Complete in-hospital Treatment in patients with Heart Failure; 30 day-Re-admissions; 30 day-mortality; Patients with in-hospital stress test performed; and, Patients included in rehabilitation programs.

Conclusion: This document provides the official set of PM of attention in ST segment Elevation Myocardial Infarction of the Cuban Society of Cardiology and Cuban National Group of Cardiology.

背景:中低收入国家 ST 段抬高型心肌梗死(STEMI)患者的绩效测量(PM)数据非常稀少。原因之一是缺乏针对这些情况的适当措施,因为冠状动脉介入并非标准治疗方法:本研究旨在为这些国家的 STEMI 患者制定一套 PM 和质量指标:两名研究人员系统地审查了现有指南和科学文献,参考从 2010 年到 2019 年在 PubMed 上搜索到的文献,使用 "心肌梗死"、"STEMI"、"质量指标 "和 "绩效衡量 "等术语来识别潜在的 PM。采用了改良的德尔菲技术,包括多学科小组访谈。由 15 名成员组成的多学科专家小组在三轮访谈中分别对每个潜在指标进行评分,评分标准从 1 分(最低)到 5 分(最高)不等。所有在最后一轮中获得中位数分数≥4.5,且无重大分歧的指标均被纳入 PM:结果:通过建立共识的过程,找到了 84 个潜在指标,其中 10 个被提议为绩效衡量指标,2 个被提议为质量衡量指标,具体如下:院前心电图、接受再灌注治疗的患者、院前再灌注、缺血时间少于 120 分钟、系统延迟时间少于 90 分钟、院内死亡率、院内完全治疗、心衰患者院内完全治疗、30 天再入院率、30 天死亡率、接受院内压力测试的患者以及纳入康复计划的患者:本文件提供了古巴心脏病学会和古巴国家心脏病学小组关于 ST 段抬高型心肌梗死注意事项的官方标准。
{"title":"A collaborative approach to develop indicators for quality of care for ST segment Elevation Myocardial Infarction in networks without coronary intervention: A position paper.","authors":"Miguel Alejandro Rodríguez-Ramos, Maikel Santos-Medina, Alfredo Dueñas-Herrera, Juan Adolfo Prohías Martínez, Eduardo Rivas-Estany","doi":"10.3233/JRS-220057","DOIUrl":"10.3233/JRS-220057","url":null,"abstract":"<p><strong>Background: </strong>Data about performance measures (PM) in patients with ST segment Elevation Myocardial Infarction (STEMI) in low- and middle-income countries is really scarce. One of the reasons is the lack of appropriate measures for these scenarios where coronary intervention is not the standard treatment.</p><p><strong>Objective: </strong>This study aimed to develop a set of PM and quality markers for patients with STEMI in these countries.</p><p><strong>Methods: </strong>Two investigators systematically reviewed existing guidelines and scientific literature to identify potential PM by referring to documents searched through PubMed from 2010 through 2019, using terms \"Myocardial Infarction\", \"STEMI\", \"quality indicator\", and \"performance measure\". A modified Delphi technique, involving multidisciplinary panel interview, was used. A 15-member multidisciplinary expert panel individually rated each potential indicator on a scale of 1 (lowest) to 5 (highest) during three rounds. All indicators that received a median score ≥4.5, in final round without significant disagreement were included as PM.</p><p><strong>Results: </strong>Through the consensus-building process, 84 potential indicators were found, of which 10 were proposed as performance measures and 2 as quality metrics, as follows: Pre-Hospital Electrocardiogram; Patients with reperfusion therapy; Pre-hospital Reperfusion; Ischemic time less than 120 minutes; System delay time less than 90 minutes; In-hospital Mortality; Complete in-hospital Treatment; Complete in-hospital Treatment in patients with Heart Failure; 30 day-Re-admissions; 30 day-mortality; Patients with in-hospital stress test performed; and, Patients included in rehabilitation programs.</p><p><strong>Conclusion: </strong>This document provides the official set of PM of attention in ST segment Elevation Myocardial Infarction of the Cuban Society of Cardiology and Cuban National Group of Cardiology.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10388194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction to IJRSM 35(2): Celebration of independent health research targeted at fostering safety of health interventions. IJRSM 35(2) 简介:庆祝以促进健康干预安全为目标的独立健康研究。
IF 0.9 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-01-01 DOI: 10.3233/JRS-246001
Liliya Eugenevna Ziganshina
{"title":"Introduction to IJRSM 35(2): Celebration of independent health research targeted at fostering safety of health interventions.","authors":"Liliya Eugenevna Ziganshina","doi":"10.3233/JRS-246001","DOIUrl":"10.3233/JRS-246001","url":null,"abstract":"","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2024, a year for furthering the value of independent health policy research to minimize risks and ensure safety in medicine for better global health. 2024 年,是进一步提高独立卫生政策研究价值的一年,目的是最大限度地降低风险,确保医疗安全,改善全球健康。
IF 1.7 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/JRS-246000
Liliya Eugenevna Ziganshina
{"title":"2024, a year for furthering the value of independent health policy research to minimize risks and ensure safety in medicine for better global health.","authors":"Liliya Eugenevna Ziganshina","doi":"10.3233/JRS-246000","DOIUrl":"10.3233/JRS-246000","url":null,"abstract":"","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139742288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of in-hospital training on medical errors made by teams during neonatal resuscitation. 院内培训对新生儿复苏团队医疗失误的影响。
IF 0.9 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-01-01 DOI: 10.3233/JRS-230056
Safaa ELMeneza, Abeer Kadom, Heba Gafar

Background: Neonatal resuscitation is one of the most critical and risky events that requires a high level of individual skill and team performance.

Objective: To evaluate the effect of training of resuscitation teams on the frequency and type of medical errors (ME) that result from neonatal resuscitation.

Methods: A prospective observational study was performed using a checklist to detect ME related to neonatal resuscitation.

Results: The rate of ME was 24.82%. There was a significant reduction in the percentage of errors from 17.28% in pre- pre-training phase to 7.54% in post post-training phase. Near miss MEs (98.77%) were significantly higher than adverse events. The active errors were significantly higher than latent errors, P < 0.001, and decreased from 39.19% during pre-training to 19.64% in the post-training phase. The commission ME s were significantly higher than the omission, P < 0.001. The latent errors percentage was 41.17% of the total errors and were not significantly reduced after training.

Conclusion: Training sessions reduced ME that occurred during resuscitation, however careful distinguishing and recognizing the type of MEs is important to plan for further reduction of errors. Special attention to latent errors is imperative as it needs a specific approach rather than just training.

背景:新生儿复苏是最关键和最危险的事件之一,需要高水平的个人技能和团队表现:目的:评估复苏团队的培训对新生儿复苏过程中医疗失误(ME)的频率和类型的影响:方法:采用检查表检测与新生儿复苏相关的医疗差错,并进行前瞻性观察研究:结果:ME 发生率为 24.82%。错误率从培训前的 17.28%大幅下降到培训后的 7.54%。近乎失误的 ME(98.77%)明显高于不良事件。主动错误明显高于潜在错误,P 结论:培训课程减少了复苏过程中发生的失误,但仔细区分和识别失误类型对于计划进一步减少失误非常重要。必须特别关注潜在错误,因为这需要一种特定的方法,而不仅仅是培训。
{"title":"Effect of in-hospital training on medical errors made by teams during neonatal resuscitation.","authors":"Safaa ELMeneza, Abeer Kadom, Heba Gafar","doi":"10.3233/JRS-230056","DOIUrl":"10.3233/JRS-230056","url":null,"abstract":"<p><strong>Background: </strong>Neonatal resuscitation is one of the most critical and risky events that requires a high level of individual skill and team performance.</p><p><strong>Objective: </strong>To evaluate the effect of training of resuscitation teams on the frequency and type of medical errors (ME) that result from neonatal resuscitation.</p><p><strong>Methods: </strong>A prospective observational study was performed using a checklist to detect ME related to neonatal resuscitation.</p><p><strong>Results: </strong>The rate of ME was 24.82%. There was a significant reduction in the percentage of errors from 17.28% in pre- pre-training phase to 7.54% in post post-training phase. Near miss MEs (98.77%) were significantly higher than adverse events. The active errors were significantly higher than latent errors, P < 0.001, and decreased from 39.19% during pre-training to 19.64% in the post-training phase. The commission ME s were significantly higher than the omission, P < 0.001. The latent errors percentage was 41.17% of the total errors and were not significantly reduced after training.</p><p><strong>Conclusion: </strong>Training sessions reduced ME that occurred during resuscitation, however careful distinguishing and recognizing the type of MEs is important to plan for further reduction of errors. Special attention to latent errors is imperative as it needs a specific approach rather than just training.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of drug utilization and potentially inappropriate medications in hemodialysis patients with end-stage renal dysfunction: A study in a tertiary care hospital in Bahrain. 评估终末期肾功能不全血液透析患者的药物使用情况和潜在的用药不当:巴林一家三级医院的研究。
IF 1.7 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.3233/JRS-230004
Kannan Sridharan

Background: Patients undergoing dialysis pose therapeutic challenges in terms of polypharmacy, administration of potentially inappropriate drugs, and drugs with the potential risk of toxicity.

Objective: This study evaluated the use of drugs, potentially inappropriate medicines (PIM), drugs with risk of Torsades de Pointes (TdP), and the complexity of the prescribed regimen using the medication regimen complexity index scale in patients undergoing hemodialysis.

Methods: A retrospective cohort study was carried out amongst patients receiving hemodialysis. Drugs were classified into one of four classes: (i) drugs used in managing renal complications, (ii) cardiovascular drugs, (iii) anti-diabetic drugs, (iv) drugs for symptomatic management, and (v) others. Drugs were considered as PIM according to the Can-SOLVE CKD working group from a network of Canadian nephrology health professionals. The study adhered to the CredibleMeds classification of drugs with known, possible, and conditional risk of TdP and the complexity of prescribed medicines was evaluated based on the pre-validated medication regimen complexity index scale based on form/route, frequency of dosing, and requirement of special instructions.

Results: Sixty-three participants were included in the study (49 males and 14 females) with the median (range) age of 45 (21-66) years. Cardiovascular drugs followed by drugs used for managing renal complications were the most common classes administered. Notably, 12 (19.1%) patients received one of the non-steroidal anti-inflammatory drugs, 21 (33.3%) received a proton pump inhibitor, three (4.8%) received pregabalin, two (3.2%) received opioid drugs, and one (1.6%) was administered celecoxib. Atorvastatin, furosemide, omeprazole, and allopurinol were the most common PIM drugs administered to the study participants followed by others. Drugs used for symptomatic management had significantly more PIM compared to other classes (p < 0.0001). Six (9.5%) patients received drugs with known TdP risk, one with possible TdP risk, and 61 with conditional risk. Median (range) medical regimen complexity index score was 26.5 (2-62.5).

Conclusion: A huge burden of drug therapy was observed in the hemodialysis patients in terms of higher proportions of PIM, complex medical regimen, and prescription of drugs with risk of TdP. Implementation of clinical decision support tools enhancing rational prescription and identification of drugs with TdP risk, introducing antimicrobial stewardship, and stepwise deprescription of the drugs with the least benefit-risk ratio are warranted.

背景:透析患者在使用多种药物、使用可能不适当的药物和具有潜在毒性风险的药物方面面临治疗挑战:本研究评估了血液透析患者的药物使用情况、潜在的不适当药物(PIM)、有发生 Torsades de Pointes(TdP)风险的药物以及处方方案的复杂性,并使用了药物方案复杂性指数量表:在接受血液透析的患者中开展了一项回顾性队列研究。药物分为四类:(i) 用于治疗肾脏并发症的药物;(ii) 心血管药物;(iii) 抗糖尿病药物;(iv) 对症治疗药物;(v) 其他。根据加拿大肾脏病医疗专业人员网络的 Can-SOLVE CKD 工作组的意见,药物被视为 PIM。该研究遵循 CredibleMeds 对已知、可能和有条件发生 TdP 风险的药物进行的分类,并根据预先验证的用药方案复杂性指数表对处方药的复杂性进行了评估,该指数表以形式/途径、用药频率和特殊说明要求为基础:研究共纳入 63 名参与者(49 名男性和 14 名女性),年龄中位数(范围)为 45(21-66)岁。最常见的用药类别是心血管药物,其次是治疗肾脏并发症的药物。值得注意的是,12 名患者(19.1%)服用了一种非甾体抗炎药,21 名患者(33.3%)服用了质子泵抑制剂,3 名患者(4.8%)服用了普瑞巴林,2 名患者(3.2%)服用了阿片类药物,1 名患者(1.6%)服用了塞来昔布。阿托伐他汀、呋塞米、奥美拉唑和别嘌醇是研究参与者最常服用的 PIM 药物,其次是其他药物。与其他类药物相比,用于对症治疗的药物的 PIM 值明显更高(P 结 论):血液透析患者的药物治疗负担沉重,PIM 比例较高,医疗方案复杂,处方药物有引发 TdP 的风险。因此,有必要使用临床决策支持工具来提高处方的合理性,并识别具有 TdP 风险的药物,引入抗菌药物管理,逐步停用效益风险比最低的药物。
{"title":"Assessment of drug utilization and potentially inappropriate medications in hemodialysis patients with end-stage renal dysfunction: A study in a tertiary care hospital in Bahrain.","authors":"Kannan Sridharan","doi":"10.3233/JRS-230004","DOIUrl":"10.3233/JRS-230004","url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing dialysis pose therapeutic challenges in terms of polypharmacy, administration of potentially inappropriate drugs, and drugs with the potential risk of toxicity.</p><p><strong>Objective: </strong>This study evaluated the use of drugs, potentially inappropriate medicines (PIM), drugs with risk of Torsades de Pointes (TdP), and the complexity of the prescribed regimen using the medication regimen complexity index scale in patients undergoing hemodialysis.</p><p><strong>Methods: </strong>A retrospective cohort study was carried out amongst patients receiving hemodialysis. Drugs were classified into one of four classes: (i) drugs used in managing renal complications, (ii) cardiovascular drugs, (iii) anti-diabetic drugs, (iv) drugs for symptomatic management, and (v) others. Drugs were considered as PIM according to the Can-SOLVE CKD working group from a network of Canadian nephrology health professionals. The study adhered to the CredibleMeds classification of drugs with known, possible, and conditional risk of TdP and the complexity of prescribed medicines was evaluated based on the pre-validated medication regimen complexity index scale based on form/route, frequency of dosing, and requirement of special instructions.</p><p><strong>Results: </strong>Sixty-three participants were included in the study (49 males and 14 females) with the median (range) age of 45 (21-66) years. Cardiovascular drugs followed by drugs used for managing renal complications were the most common classes administered. Notably, 12 (19.1%) patients received one of the non-steroidal anti-inflammatory drugs, 21 (33.3%) received a proton pump inhibitor, three (4.8%) received pregabalin, two (3.2%) received opioid drugs, and one (1.6%) was administered celecoxib. Atorvastatin, furosemide, omeprazole, and allopurinol were the most common PIM drugs administered to the study participants followed by others. Drugs used for symptomatic management had significantly more PIM compared to other classes (p < 0.0001). Six (9.5%) patients received drugs with known TdP risk, one with possible TdP risk, and 61 with conditional risk. Median (range) medical regimen complexity index score was 26.5 (2-62.5).</p><p><strong>Conclusion: </strong>A huge burden of drug therapy was observed in the hemodialysis patients in terms of higher proportions of PIM, complex medical regimen, and prescription of drugs with risk of TdP. Implementation of clinical decision support tools enhancing rational prescription and identification of drugs with TdP risk, introducing antimicrobial stewardship, and stepwise deprescription of the drugs with the least benefit-risk ratio are warranted.</p>","PeriodicalId":45237,"journal":{"name":"INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139940901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1